Anti-inflammatory and Analgesic Effect of Plumbagin through Inhibition of Nuclear Factor-κB Activation
Authors:
- Yuen Fan WongYWYuen Fan Wong
- Lin GeLGLin Ge
- Zhi Feng ZhangZZZhi Feng Zhang
- Yuan LiuYLYuan Liu
- Liang LiuLLLiang Liu
- Hua ZhouHZHua Zhou
- 1 December 2010
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 335 (3) , 735-742
Abstract
Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) (PL) is a naturally occurring yellow pigment found in the plants of the Plumbaginaceae, Droseraceae, Ancistrocladaceae, and Dioncophyllaceae families. It has been reported that PL exhibits anticarcinogenic, anti-inflammatory, and analgesic activities. However, the mechanism underlying its anti-inflammatory action remains unknown. In the current study, we investigated and characterized the anti-inflammatory and analgesic effects of PL orally administrated in a range of dosages from 5 to 20 mg/kg. We also examined the role of nuclear factor κB (NF-κB) and proinflammatory cytokines and mediators in this effect. The results showed that PL significantly and dose-dependently suppressed the paw edema of rats induced by carrageenan and various proinflammatory mediators, including histamine, serotonin, bradykinin, and prostaglandin E2. PL reduced the number of writhing episodes of mice induced by the intraperitoneal injection of acetic acid, but it did not reduce the writhing episode numbers induced by MgSO4 in mice or prolong the tail-flick reaction time of rats to noxious thermal pain. Mechanistic studies showed that PL effectively decreased the production of the proinflammatory cytokines interleukin 1β, interleukin 6, and tumor necrosis factor α. It also inhibited the expression of the proinflammatory mediators inducible nitric-oxide synthase and cyclooxygenase 2, whereas it did not inhibit the expression of cyclooxygenase 1. Further studies demonstrated that PL suppressed inhibitor of κBα phosphorylation and degradation, thus inhibiting the phosphorylation of the p65 subunit of NF-κB. This study suggests that PL has a potential to be developed into an anti-inflammatory agent for treating inflammatory diseases.Keywords
This publication has 35 references indexed in Scilit:
- Bioassay-guided isolation of anti-inflammatory and antinociceptive compound fromPlumbago zeylanicaleafPharmaceutical Biology, 2010
- Anti‐nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1adenosine receptorsBritish Journal of Pharmacology, 2008
- Anti‐inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX‐2 expression in RAW 264.7 macrophages via the NF‐κB inactivationBritish Journal of Pharmacology, 2006
- Inhibition of Nox-4 activity by plumbagin, a plant-derived bioactive naphthoquinoneJournal of Pharmacy and Pharmacology, 2005
- Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cellsMolecular Carcinogenesis, 2004
- Long-patch base excision repair of apurinic/apyrimidinic site DNA is decreased in mouse embryonic fibroblast cell lines treated with plumbagin: involvement of cyclin-dependent kinase inhibitor p21Waf-1/Cip-1Oncogene, 2002
- Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activationMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2001
- Effect of calpain inhibitor I, an inhibitor of the proteolysis of IκB, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the ratBritish Journal of Pharmacology, 1997
- Antiinflammatory effect of Curcuma xanthorrhiza Roxb. and its active principles.Chemical and Pharmaceutical Bulletin, 1990
- A method for evaluating analgesic agents in ratsJournal of Pharmacological Methods, 1980